Stock Research for GBLX

GBLX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

GBLX Stock Chart & Research Data

The GBLX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GBLX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


GBLX Due diligence Resources & Stock Charts

The GBLX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View GBLX Detailed Price Forecast - CNN Money CNN View GBLX Detailed Summary - Google Finance
Yahoo View GBLX Detailed Summary - Yahoo! Finance Zacks View GBLX Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View GBLX Trends & Analysis - Trade-Ideas Barrons View GBLX Major Holders - Barrons
NASDAQ View GBLX Call Transcripts - NASDAQ Seeking View GBLX Breaking News & Analysis - Seeking Alpha
Spotlight View GBLX Annual Report - CompanySpotlight.com OTC Report View GBLX OTC Short Report - OTCShortReport.com
TradeKing View GBLX Fundamentals - TradeKing Charts View GBLX SEC Filings - Bar Chart
WSJ View Historical Prices for GBLX - The WSJ Morningstar View Performance/Total Return for GBLX - Morningstar
MarketWatch View the Analyst Estimates for GBLX - MarketWatch CNBC View the Earnings History for GBLX - CNBC
StockMarketWatch View the GBLX Earnings - StockMarketWatch MacroAxis View GBLX Buy or Sell Recommendations - MacroAxis
Bullish View the GBLX Bullish Patterns - American Bulls Short Pains View GBLX Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View GBLX Stock Mentions - StockTwits PennyStocks View GBLX Stock Mentions - PennyStockTweets
Twitter View GBLX Stock Mentions - Twitter Invest Hub View GBLX Investment Forum News - Investor Hub
Yahoo View GBLX Stock Mentions - Yahoo! Message Board Seeking Alpha View GBLX Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for GBLX - SECform4.com Insider Cow View Insider Transactions for GBLX - Insider Cow
CNBC View GBLX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for GBLX - OTC Markets
Yahoo View Insider Transactions for GBLX - Yahoo! Finance NASDAQ View Institutional Holdings for GBLX - NASDAQ


Stock Charts

FinViz View GBLX Stock Insight & Charts - FinViz.com StockCharts View GBLX Investment Charts - StockCharts.com
BarChart View GBLX Stock Overview & Charts - BarChart Trading View View GBLX User Generated Charts - Trading View




Latest Financial News for GBLX


Gb Sciences’ Novel Parkinson’s Disease Medication is Featured on Worldwide Business with kathy ireland(R)
Posted on Thursday December 14, 2023

Tune in this Sunday, Dec. 17, at 5:30 p.m. ET on the Fox Business Network to learn about Gb Sciences' cannabinoid-based medicine for the treatment of Parkinson's disease.LAS VEGAS, NV / ACCESSWIRE / December 14, 2023 / Gb Sciences, Inc. (OTCQB:GBLX), ...


Gb Sciences' First-in-Class Parkinson's Disease Therapy Successfully Completes Dose Response Study at the University of Lethbridge
Posted on Tuesday July 11, 2023

Gb Sciences, Inc. (OTCQB:GBLX), a leading cannabis- and plant-inspired biopharmaceutical research and development company, has successfully completed a dose response study in rodents at the University of Lethbridge that supports Gb Sciences' cannabinoid-based therapy for Parkinson's disease. The study has established dose ranges and the corresponding times to onset and duration of action in a rodent model.


GB Sciences' First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson's Disease Has Been Issued in China
Posted on Monday March 20, 2023

Gb Sciences, Inc. (OTCQB:GBLX), a leading cannabis- and plant-inspired biopharmaceutical research and development company, has recently been issued a patent in China to protect its proprietary cannabinoid-containing formulation for the treatment of Parkinson's disease. China is an increasingly important pharmaceutical market with cultural acceptance of plant-based formulations, which is a good fit for Gb Sciences' drug candidates.


Successful 2022 Milestones Support Value of Gb Sciences' AI-Enabled Drug Discovery Platform
Posted on Tuesday March 07, 2023

Gb Sciences, Inc. (OTCQB:GBLX), a leading cannabis- and plant-inspired biopharmaceutical research and development company, issued a letter to shareholders today from President, Chief Science Officer, and Director Dr. Andrea Small-Howard and Chairman and CEO John Poss summarizing key developments from 2022 and providing strategic plans for 2023.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.